Cytomegalovirus kinetics after hematopoietic cell transplantation reveal peak titers with differential impact on mortality, relapse and immune reconstitution-Reference-Cited by-同舟云学术

Cytomegalovirus kinetics after hematopoietic cell transplantation reveal peak titers with differential impact on mortality, relapse and immune reconstitution

Published:2021-02-12 Issue:4 Volume:96 Page:436-445
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Leserer Saskia¹²³,Bayraktar Evren¹²⁴,Trilling Mirko⁵,Bogdanov Rashit¹²,Arrieta‐Bolaños Esteban³⁶,Tsachakis‐Mück Nikolaos¹,Crivello Pietro³^ORCID,Koldehoff Michael¹,Maaßen Fabienne³⁵,Ross Rudolf Stefan⁵,Fleischhauer Katharina³⁶,Beelen Dietrich W.¹,Turki Amin T.¹²³^ORCID

Affiliation:

1. Department of Hematology and Stem Cell Transplantation, West‐German Cancer Center University Hospital Essen Essen Germany

2. Computational Hematology Workgroup, Department of Hematology and Stem Cell Transplantation, West‐German Cancer Center University Hospital Essen Essen Germany

3. Institute for Experimental Cellular Therapy, West‐German Cancer Center University Hospital Essen Essen Germany

4. Chair of Applied Mathematics and Numerics III TU Dortmund University Dortmund Germany

5. Institute for Virology University Hospital Essen, University Duisburg‐Essen Essen Germany

6. German Cancer Consortium (DKTK) Heidelberg Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26094

Reference45 articles.

1. Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies

2. A risk score for early cytomegalovirus reactivation after allogeneic stem cell transplantation identifies low-, intermediate-, and high-risk groups: reactivation risk is increased by graft-versus-host disease only in the intermediate-risk group

3. The role of cytomegalovirus serostatus on outcome of hematopoietic stem cell transplantation

4. Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell–depleted stem cell transplantation

5. CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytomegalovirus in haematopoietic cell transplantation - The troll is still there;Best Practice & Research Clinical Haematology;2024-09

2. Cytomegalovirus viral load at initiation of pre‐emptive antiviral therapy impacts cytomegalovirus dynamics in pediatric allogeneic hematopoietic cell transplantation recipients;Transplant Infectious Disease;2024-08-26

3. Immune reconstitution in children after haploidentical haematopoietic stem cell transplantation;International Journal of Laboratory Hematology;2024-04-22

4. Comparison of valganciclovir versus foscarnet for the treatment of cytomegalovirus viremia in adult acute leukemia patients after allogeneic hematopoietic cell transplantation;Leukemia & Lymphoma;2024-03-12

5. Immune reconstitution after hematopoietic stem cell transplantation with reduced intensity conditioning for inborn errors of immunity;2024-01-03